| Clarence S Greene Jr, MD | |
|
200 Henry Clay Ave, Neurosurgery Department, New Orleans, LA 70118-5720 | |
| (504) 896-9568 | |
| (504) 896-3966 |
| Full Name | Clarence S Greene Jr |
|---|---|
| Gender | Male |
| Speciality | Neurological Surgery |
| Location | 200 Henry Clay Ave, New Orleans, Louisiana |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215960059 | NPI | - | NPPES |
| 209327402 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | MD.203792 (Louisiana) | Primary |
| Entity Name | Louisiana State University School Of Medicine In New Orleans Faculty G |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477582526 PECOS PAC ID: 0244136448 Enrollment ID: O20031209000661 |
News Archive
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported its financial results for the quarter ended September 30, 2009.
"Reports of a French study to examine the effects of DEET on the nervous system of insects has little relevance for the widely-used repellent ingredient's effects on humans, according to independent scientific experts, including those at the U.S. National Pesticide Information Center," said Susan Little, director of the DEET Education Program, Washington, D.C.
A new study published in the journal of Minerva Cardioangiologica reveals Pycnogenol, pine bark extract from the French maritime pine tree, reduces jetlag in passengers by nearly 50 percent.
TWi Biotechnology Inc. today announced interim results from the ongoing Phase 2 proof of concept clinical study evaluating AC-201 CR as an oral uricosuric and anti-inflammatory agent for the treatment of hyperuricemia and prevention of gout flares combining with febuxostat, a xanthine oxidase inhibitor.
› Verified 6 days ago
| Entity Name | Children's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043230873 PECOS PAC ID: 3971401944 Enrollment ID: O20031229000715 |
News Archive
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported its financial results for the quarter ended September 30, 2009.
"Reports of a French study to examine the effects of DEET on the nervous system of insects has little relevance for the widely-used repellent ingredient's effects on humans, according to independent scientific experts, including those at the U.S. National Pesticide Information Center," said Susan Little, director of the DEET Education Program, Washington, D.C.
A new study published in the journal of Minerva Cardioangiologica reveals Pycnogenol, pine bark extract from the French maritime pine tree, reduces jetlag in passengers by nearly 50 percent.
TWi Biotechnology Inc. today announced interim results from the ongoing Phase 2 proof of concept clinical study evaluating AC-201 CR as an oral uricosuric and anti-inflammatory agent for the treatment of hyperuricemia and prevention of gout flares combining with febuxostat, a xanthine oxidase inhibitor.
› Verified 6 days ago
| Entity Name | Louisiana State University School Of Med In New Orleans Faculty Grou |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932492626 PECOS PAC ID: 9739358722 Enrollment ID: O20110810000538 |
News Archive
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported its financial results for the quarter ended September 30, 2009.
"Reports of a French study to examine the effects of DEET on the nervous system of insects has little relevance for the widely-used repellent ingredient's effects on humans, according to independent scientific experts, including those at the U.S. National Pesticide Information Center," said Susan Little, director of the DEET Education Program, Washington, D.C.
A new study published in the journal of Minerva Cardioangiologica reveals Pycnogenol, pine bark extract from the French maritime pine tree, reduces jetlag in passengers by nearly 50 percent.
TWi Biotechnology Inc. today announced interim results from the ongoing Phase 2 proof of concept clinical study evaluating AC-201 CR as an oral uricosuric and anti-inflammatory agent for the treatment of hyperuricemia and prevention of gout flares combining with febuxostat, a xanthine oxidase inhibitor.
› Verified 6 days ago
| Entity Name | Our Lady Of The Lake Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033494943 PECOS PAC ID: 4587849781 Enrollment ID: O20120529000377 |
News Archive
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported its financial results for the quarter ended September 30, 2009.
"Reports of a French study to examine the effects of DEET on the nervous system of insects has little relevance for the widely-used repellent ingredient's effects on humans, according to independent scientific experts, including those at the U.S. National Pesticide Information Center," said Susan Little, director of the DEET Education Program, Washington, D.C.
A new study published in the journal of Minerva Cardioangiologica reveals Pycnogenol, pine bark extract from the French maritime pine tree, reduces jetlag in passengers by nearly 50 percent.
TWi Biotechnology Inc. today announced interim results from the ongoing Phase 2 proof of concept clinical study evaluating AC-201 CR as an oral uricosuric and anti-inflammatory agent for the treatment of hyperuricemia and prevention of gout flares combining with febuxostat, a xanthine oxidase inhibitor.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Clarence S Greene Jr, MD 200 Henry Clay Ave, Neurosurgery Department, New Orleans, LA 70118-5720 Ph: (504) 896-9568 | Clarence S Greene Jr, MD 200 Henry Clay Ave, Neurosurgery Department, New Orleans, LA 70118-5720 Ph: (504) 896-9568 |
News Archive
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today reported its financial results for the quarter ended September 30, 2009.
"Reports of a French study to examine the effects of DEET on the nervous system of insects has little relevance for the widely-used repellent ingredient's effects on humans, according to independent scientific experts, including those at the U.S. National Pesticide Information Center," said Susan Little, director of the DEET Education Program, Washington, D.C.
A new study published in the journal of Minerva Cardioangiologica reveals Pycnogenol, pine bark extract from the French maritime pine tree, reduces jetlag in passengers by nearly 50 percent.
TWi Biotechnology Inc. today announced interim results from the ongoing Phase 2 proof of concept clinical study evaluating AC-201 CR as an oral uricosuric and anti-inflammatory agent for the treatment of hyperuricemia and prevention of gout flares combining with febuxostat, a xanthine oxidase inhibitor.
› Verified 6 days ago
Robert L Applebaum, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 3434 Prytania St., Suite 230, New Orleans, LA 70115 Phone: 504-340-6976 Fax: 504-349-6786 | |
Pervez Ahmad Khan, MBBS Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1415 Tulane Ave Fl 5, New Orleans, LA 70112 Phone: 504-988-5561 Fax: 504-988-1731 | |
Derrick Umansky, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 131 S Robertson St, #8047, New Orleans, LA 70112 Phone: 504-988-5565 | |
Dr. Aaron S. Dumont, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 131 S Robertson St, Suite 1300, New Orleans, LA 70112 Phone: 504-988-5565 Fax: 504-988-5793 | |
Dr. Olawale A. R. Sulaiman, MD, PHD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 1514 Jefferson Highway, New Orleans, LA 70121 Phone: 504-842-4000 | |
Arthur Wang, Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 1430 Tulane Ave # 8047, New Orleans, LA 70112 Phone: 504-988-3524 | |
Dr. Bradley Joseph Bartholomew, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 3629 Prytania St, New Orleans, LA 70115 Phone: 504-895-9544 Fax: 504-895-9548 |